CRISPR Therapeutics AG

BENJAMIN EDWARDS INC CRSP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

54,636

Value ($000)

2,865

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	2,865	0.0%	54,636	12/31/2025
2025 Q3	10/23/2025	3,514	0.0%	54,220	9/30/2025
2025 Q2	8/14/2025	2,809	0.0%	57,760	6/30/2025
2025 Q1	5/12/2025	1,733	0.0%	50,915	3/31/2025
2024 Q4	2/14/2025	1,774	0.0%	45,062	12/31/2024
2024 Q3	11/14/2024	1,536	0.0%	32,703	9/30/2024
2024 Q2	8/12/2024	13	0.0%	238	6/30/2024
2024 Q1	4/29/2024	25	0.0%	369	3/31/2024
2023 Q4	2/6/2024	21	0.0%	339	12/31/2023
2023 Q3	11/13/2023	23	0.0%	504	9/30/2023
2023 Q2	8/15/2023	28	0.0%	491	6/30/2023
2023 Q1	4/27/2023	25	0.0%	558	3/31/2023
2022 Q4	2/7/2023	21	0.0%	528	12/31/2022
2022 Q3	10/28/2022	28	0.0%	421	9/30/2022
2022 Q2	8/12/2022	30	0.0%	499	6/30/2022
2022 Q1	5/4/2022	30	0.0%	480	3/31/2022
2021 Q4	2/7/2022	36	0.0%	470	12/31/2021
2021 Q3	11/2/2021	44	0.0%	396	9/30/2021
2021 Q2	8/11/2021	66	0.0%	410	6/30/2021
2021 Q1	5/14/2021	58	0.0%	478	3/31/2021
2020 Q4	2/16/2021	83	0.1%	545	12/31/2020
2020 Q3	11/16/2020	65	0.1%	778	9/30/2020
2020 Q2	8/14/2020	54	0.0%	730	6/30/2020
2020 Q1	5/7/2020	31	0.0%	730	3/31/2020
2019 Q4	2/6/2020	38	0.1%	621	12/31/2019